MALIGNANT SOLID TUMOR
Clinical trials for MALIGNANT SOLID TUMOR explained in plain language.
Never miss a new study
Get alerted when new MALIGNANT SOLID TUMOR trials appear
Sign up with your email to follow new studies for MALIGNANT SOLID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental cancer drug GEN1078 trial halted after just 3 patients
Disease control TerminatedThis trial tested a new drug, GEN1078, in people with advanced solid tumors that had stopped responding to standard treatments. The study was stopped early after enrolling only 3 participants. Its main goals were to check for side effects, see how the drug moves through the body,…
Matched conditions: MALIGNANT SOLID TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Genmab • Aim: Disease control
Last updated May 26, 2026 09:11 UTC
-
New drug combo tested for tough cancers
Disease control TerminatedThis early-stage study tested a new drug called ZL-1218, alone or with another cancer drug, in 34 adults with advanced solid tumors that had stopped responding to standard treatments. The main goals were to check safety, find the right dose, and see if the drug shrinks tumors. Th…
Matched conditions: MALIGNANT SOLID TUMOR
Phase: PHASE1 • Sponsor: Zai Lab (Hong Kong), Ltd. • Aim: Disease control
Last updated May 26, 2026 09:04 UTC
-
New antibody combo shows promise against tough cancers
Disease control TerminatedThis trial tested a new antibody drug called GEN1055, alone or with pembrolizumab (and sometimes chemotherapy), in 21 adults with advanced solid tumors. The goal was to check safety and find the best dose, and to see if the drug could shrink tumors. The study was stopped early, b…
Matched conditions: MALIGNANT SOLID TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Genmab • Aim: Disease control
Last updated May 26, 2026 08:33 UTC